Lightstone Ventures — 2016 Investments
4 investments dated 2016 · listed companies and verified rows first · show all
Tangible Science develops contact lens solutions designed to improve comfort and durability for wearers and to provide eye care professionals with more effective treatment options.
HealthtechMedical DevicesMenlo Park, US
Karen Havenstrite(Director)Victor McCray(Executive Officer, Director)
BoardDouglas Crawford(Director)inHanson Gifford(Director)Chip Heath(Director)Brandon Felkins(Director)
Board seatHanson S. Gifford· per SEC Form D · $4.6M raise · filed Nov 2016
Co-investorsMission Biocapital
BiotechCambridge, US
James McLaughlin(Executive Officer, Director)
BoardJean George(Director)Jason Rhodes(Director)Carl Gordon(Director)in
Co-investorsAtlas VentureOrbiMed
Day One (part of Servier) is a biopharmaceutical company developing targeted oncology medicines, with a focus on cancers affecting patients of all ages, including pediatric low-grade glioma (pLGG).
BiotechHealthtechCambridge, US
MICHAEL J. KAUFMAN(Executive Officer)DONALD BERGSTROM(Executive Officer)ANNA PROTOPAPAS(Executive Officer, Director)TIMOTHY LOWINGER(Executive Officer)EVA JACK(Executive Officer)WAYNE FOSTER(Executive Officer)
Co-investorsBain Capital Life SciencesF-Prime CapitalNew Enterprise Associates (NEA)Nextech InvestPfizer Venture InvestmentsRho Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.